Skip to main content
UniHealth

Doctor search

Deborah J Levine, MD

Pulmonary Disease · Stanford

NPI 1831206804

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
1 carrier
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · University Health System. That is not proof they admit you there this week.

Plans that list them

12 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Levine’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence C181690 · Current

Licensed to practise in California · since 2022 · expires 2028-09-30 · University of Arizona College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Texas M1881Physician License · since 2005 · expires 2023-08-31
    Canc Non-RenewalNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • University Health SystemSan Antonio, TXAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University Health SystemPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.405, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.388, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.3, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.361, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for University Health System

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at University Health System
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.405BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.388BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.3BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.361BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,792 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.97 (0.7 to 1.25)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths150.43 (105.5 to 195.36) · 136 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 40 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.7 · 29 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.6 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.6 · 162 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13.3 · 185 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12.3 · 254 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.6 · 3,580 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.15 (0 to 0.36) · 6,576 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 6,682 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.61 (0.71 to 4.51) · 2,071 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.22 (0.76 to 3.69) · 678 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.78 (0.51 to 3.05) · 2,029 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.56 (0.92 to 12.2) · 778 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.58 (2.42 to 8.75) · 759 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.12 (0.7 to 3.55) · 509 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.93 (0.36 to 1.5) · 6,250 casesNo differentJul 2022 – Jun 2024
SSI - Abdominal HysterectomyInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.547No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.2 · 181 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.6 · 405 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits8.8 · 88 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits20.2 · 189 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-16 · 197 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 395 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5 (3.3 to 7.6) · 73 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.8 (7.9 to 14.9) · 73 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits9.5 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits18.6 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.2 (9.8 to 17.7) · 492 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.5) · 362 casesNo differentJan 2024 – Dec 2024

What patients said (2,347 patients answered, 22% of those asked)

Patient survey stars by topic at University Health System
Cleanliness4
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness4
Recommend hospital5
Share of patients giving the best answer at University Health System
Room was "always" clean76%
Nurses "always" communicated well78%
Doctors "always" communicated well79%
Staff "always" explained60%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)77%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect85%
"Always" quiet at night59%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects48%
Yes, staff "did" give patients information about possible symptoms85%

Original Medicare doctor bills

$114,833

Medicare paid this office $114,833 for 138 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes67$43,217$106
Critical care, first 30-74 minutes28$37,749$186
Long return visit (40+ min)84$16,547$124
Initial hospital care with moderate level of medical decision making at least 75 minutes35$6,498$155
Irrigation and suction of lung airways to obtain cells using an endoscope15$3,297$89
See all 6 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes67$43,217$106
Critical care, first 30-74 minutes28$37,749$186
Long return visit (40+ min)84$16,547$124
Initial hospital care with moderate level of medical decision making at least 75 minutes35$6,498$155
Irrigation and suction of lung airways to obtain cells using an endoscope15$3,297$89
Hospital discharge day management, 30 minutes or less31$2,391$72

Who their Medicare patients are

138 Original Medicare patients in 2024. Average age 63 · Under 65 41% · Women 46% · Also on Medicaid 42% · Health risk score 4.37. Sicker patients than 9 in 10 peers; the typical pulmonary disease clinician is at 2.13.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 70% · COPD 61% · Atrial fibrillation 45% · Coronary heart disease 43% · Heart failure 41% · Depression 36% · Dementia 14% · Cancer 12% · Stroke 12%.

The office billed $715,522, Medicare allowed $145,180 and paid $114,833; for 900 services of 15 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024138900634.37$715,522$114,833
2023131849643.99$554,431$104,280
202256285653.58$163,534$30,741
2021121284662.37$23,423$7,354
202050185663.82$45,031$13,534
201961202653.08$45,049$14,118
201861127653.35$21,473$7,864
2017100292643.74$49,362$18,696
2016110404632.75$85,389$30,278
2015114423623.54$77,529$27,502
2014122498633.26$115,517$40,097
2013130438623.09$84,180$28,390

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes58$43,039$110
Critical care, first 30-74 minutes20$25,017$191
Long return visit (40+ min)88$16,971$131
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes16$3,575$73
Irrigation and suction of lung airways to obtain cells using an endoscope20$3,272$91
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,719$160
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$2,033$120
Hospital discharge day management, 30 minutes or less18$1,518$76

2022: 4 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$16,634$93
Critical care, first 30-74 minutes12$6,204$188
Long return visit (40+ min)19$2,421$121
Irrigation and suction of lung airways to obtain cells using an endoscope11$1,813$113

2021: 9 services

Original Medicare services billed in 2021
Return visit (30+ min)23$2,021$78
Test to measure expiratory airflow and volume59$567$7
Test to determine lung volumes using sensors27$253$9
Test for exercise-induced lung stress12$215$18
Test to examine how well the lungs exchange gases26$180$7
Test to measure expiratory airflow and volume changes before and after medication administration21$167$8
Test to determine lung volumes using sensors15$145$10
Test to measure expiratory airflow and volume changes before and after medication administration15$124$8
Test to examine how well the lungs exchange gases13$93$7

2020: 4 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$4,160$82
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes17$2,855$56
Return visit (30+ min)15$1,386$58
Long return visit (40+ min)14$1,295$76

2019: 3 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes15$3,403$77
Return visit (30+ min)43$3,396$60
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes19$3,063$52

2018: 2 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$2,052$55
Return visit (30+ min)32$1,947$53

2017: 5 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$5,160$81
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes26$4,421$55
Return visit (30+ min)46$3,432$54
Return visit (30+ min)28$1,821$61
Short return visit (20+ min)16$575$36

2016: 5 services

Original Medicare services billed in 2016
Critical care, first 30-74 minutes16$9,098$162
Return visit (30+ min)74$6,697$59
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes38$5,898$54
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$4,457$78
Short return visit (20+ min)23$980$38

2015: 4 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes40$11,572$55
Critical care, first 30-74 minutes14$7,435$155
Return visit (30+ min)67$5,399$52
Short return visit (20+ min)32$1,233$36

2014: 5 services

Original Medicare services billed in 2014
Critical care, first 30-74 minutes23$17,783$171
Return visit (30+ min)87$7,751$53
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes36$7,159$54
Irrigation and suction of lung airways to obtain cells using an endoscope12$2,092$80
Short return visit (20+ min)27$1,096$38

2013: 4 services

Original Medicare services billed in 2013
Return visit (30+ min)96$9,167$53
Critical care, first 30-74 minutes15$7,642$163
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes33$7,032$52
Short return visit (20+ min)30$1,230$35

Medicaid work

$2,295 in 2024

Medicaid paid $2,295 for 46 billed services this clinician did in 2024, up to 16 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)46$2,295
Medicaid work by year
202446116$2,295
2023314225$8,428
202232112$1,181
2021177324$1,310
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES229$5,723
Long return visit (40+ min)85$2,704

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES32$1,181

2021

Largest Medicaid services in 2021
Plethysmography for determination of lung volumes and, when performed, airway resistance65$560
EVALUATION OF WHEEZING56$391
Diffusing capacity56$360

Drugs they prescribed that Part D paid

$516,985

Pharmacies billed $516,985 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,335) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.

1,160 generic and fewer than 11 brand-name prescriptions · $516,985 in drug cost · 129 antibiotic prescriptions to 47 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Cresemba24$147,776$6,157
Prevymis12$95,910$7,992
Posaconazole60$65,252$1,088
Everolimus20$24,602$1,230
Itraconazole53$22,601$426
See all 32 drugs
Every Part D drug this clinician prescribed
Cresemba24$147,776$6,157
Prevymis12$95,910$7,992
Posaconazole60$65,252$1,088
Everolimus20$24,602$1,230
Itraconazole53$22,601$426
Eliquis25$19,976$799
Valganciclovir78$13,145$169
Atovaquone24$10,834$451
Breo Ellipta17$6,544$385
Tacrolimus58$4,887$84
Advair Diskus12$2,362$197
Sps12$1,665$139
Mycophenolate Mofetil26$1,547$60
Acyclovir81$1,050$13
Ventolin Hfa14$682$49
Rosuvastatin50$648$13
Mirtazapine40$638$16
Pantoprazole62$587$9
Prednisone79$564$7
Azithromycin30$500$17
Sulfamethoxazole-Trimethoprim73$272$4
Metoclopramide16$250$16
Warfarin18$240$13
Tamsulosin14$206$15
Amlodipine Besylate55$183$3
Metoprolol54$167$3
Carvedilol16$88$5
Famotidine22$85$4
Pravastatin15$44$3
Finasteride12$29$2
Citalopram Hbr11$17$2
Amoxicillin13$13$1

Year by year

Part D prescribing by year
20241,3351520% (0)None$516,985
20236411030% (0)15%$858,365
2022407570% (0)39%$2,504,570
202168270NoneNone$3,529,247
20201,097109NoneNone$3,876,156
20191,5381491% (17)28%$3,646,978
20181,494142NoneNone$3,804,545
20171,7481541% (12)34%$4,010,314
20161,6831401% (19)37%$3,585,452
20151,9561371% (27)43%$3,918,387
20142,2441351% (32)47%$4,083,347
20131,7861162% (27)53%$3,556,495

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Part D drugs prescribed in 2023
Cresemba28$241,127$8,612
Uptravi12$235,031$19,586
Posaconazole26$93,805$3,608
Valganciclovir56$14,040$251
Everolimus13$13,812$1,062
Itraconazole24$9,775$407
Sildenafil Citrate15$5,060$337
Tacrolimus19$1,373$72
Dofetilide11$623$57
Mycophenolate Mofetil11$601$55
Mirtazapine22$578$26
Sulfamethoxazole-Trimethoprim49$566$12
Acyclovir43$539$13
Prednisone37$274$7
Pantoprazole19$225$12
Rosuvastatin12$199$17
Azithromycin15$187$12
Amlodipine Besylate12$83$7
Metoprolol16$41$3

2022: 9 drugs

Part D drugs prescribed in 2022
Uptravi33$698,552$21,168
Opsumit50$660,109$13,202
Ambrisentan73$330,020$4,521
Letairis25$304,967$12,199
Orenitram Er15$161,136$10,742
Tadalafil43$57,813$1,344
Adcirca13$54,003$4,154
Sildenafil Citrate90$35,852$398
Pantoprazole13$322$25

2021: 15 drugs

Part D drugs prescribed in 2021
Uptravi47$944,440$20,094
Opsumit67$810,708$12,100
Letairis37$414,634$11,206
Ambrisentan83$377,511$4,548
Orenitram Er35$367,435$10,498
Remodulin12$181,531$15,128
Prolastin C12$147,560$12,297
Adcirca22$92,940$4,225
Tadalafil67$82,768$1,235
Sildenafil Citrate112$33,872$302
Valganciclovir13$8,207$631
Pantoprazole32$408$13
Potassium Chloride14$377$27
Sulfamethoxazole-Trimethoprim19$240$13
Furosemide13$40$3

2020: 24 drugs

Part D drugs prescribed in 2020
Opsumit94$1,060,329$11,280
Uptravi57$993,637$17,432
Ambrisentan92$392,501$4,266
Letairis30$288,486$9,616
Orenitram Er24$236,569$9,857
Arikayce12$137,707$11,476
Adcirca23$83,784$3,643
Cresemba15$80,989$5,399
Posaconazole11$72,884$6,626
Valganciclovir44$36,213$823
Tadalafil54$34,351$636
Alyq11$24,969$2,270
Sildenafil Citrate143$24,929$174
Cefoxitin28$18,818$672
Advair Diskus12$4,978$415
Tacrolimus20$4,064$203
Pantoprazole54$1,039$19
Azithromycin27$935$35
Sulfamethoxazole-Trimethoprim61$567$9
Metoprolol50$474$9
Rosuvastatin15$327$22
Prednisone26$276$11
Potassium Chloride12$217$18
Furosemide25$78$3

2019: 29 drugs

Part D drugs prescribed in 2019
Uptravi67$1,023,587$15,277
Letairis100$968,498$9,685
Opsumit64$623,165$9,737
Ambrisentan39$177,943$4,563
Adcirca40$163,036$4,076
Tadalafil68$156,375$2,300
Cresemba20$103,285$5,164
Valganciclovir77$59,422$772
Sildenafil Citrate160$27,727$173
Atovaquone13$22,553$1,735
Enoxaparin16$9,163$573
Tacrolimus49$5,787$118
Levemir Flextouch12$5,593$466
Advair Diskus11$4,431$403
Mycophenolate Mofetil28$3,185$114
Esomeprazole Magnesium12$1,576$131
Azithromycin22$1,358$62
Pantoprazole91$1,211$13
Prednisone85$1,083$13
Sulfamethoxazole-Trimethoprim99$796$8
Metoprolol67$605$9
Rosuvastatin20$363$18
Potassium Chloride20$341$17
Acyclovir15$239$16
Furosemide25$229$9
Atorvastatin24$196$8
Ranitidine12$113$9
Tramadol13$70$5
Amoxicillin11$15$1

2018: 24 drugs

Part D drugs prescribed in 2018
Letairis146$1,356,883$9,294
Uptravi67$1,223,355$18,259
Adcirca105$411,706$3,921
Opsumit23$211,193$9,182
Revatio12$184,498$15,375
Valganciclovir65$67,786$1,043
Sildenafil183$53,761$294
Tadalafil11$36,339$3,304
Atovaquone21$22,876$1,089
Advair Diskus21$9,370$446
Tacrolimus65$7,618$117
Enoxaparin11$3,194$290
Esomeprazole Magnesium20$2,573$129
Mycophenolate Mofetil16$2,351$147
Azithromycin34$1,659$49
Pantoprazole96$941$10
Prednisone77$824$11
Sulfamethoxazole-Trimethoprim101$748$7
Potassium Chloride32$650$20
Metoprolol61$446$7
Rosuvastatin13$438$34
Furosemide23$236$10
Atorvastatin15$199$13
Amlodipine Besylate13$98$8

2017: 31 drugs

Part D drugs prescribed in 2017
Letairis179$1,584,556$8,852
Uptravi49$819,021$16,715
Adcirca130$502,470$3,865
Tracleer19$198,904$10,469
Revatio12$177,574$14,798
Valganciclovir81$132,472$1,635
Sildenafil161$103,786$645
Opsumit12$101,898$8,491
Sporanox12$20,941$1,745
Voriconazole12$16,830$1,403
Atovaquone18$11,310$628
Tacrolimus62$10,650$172
Entecavir13$7,119$548
Enoxaparin19$6,909$364
Mycophenolate Mofetil50$6,021$120
Nexium13$5,372$413
Esomeprazole Magnesium16$5,316$332
Pantoprazole128$1,227$10
Sulfamethoxazole-Trimethoprim135$1,049$8
Prednisone101$1,048$10
Azithromycin22$936$43
Rosuvastatin16$547$34
Metoprolol82$524$6
Potassium Chloride25$520$21
Atorvastatin19$256$13
Furosemide38$177$5
Gabapentin15$132$9
Ranitidine11$110$10
Escitalopram13$103$8
Sertraline15$84$6
Amlodipine Besylate24$70$3

2016: 28 drugs

Part D drugs prescribed in 2016
Letairis219$1,777,552$8,117
Adcirca156$513,139$3,289
Revatio36$348,568$9,682
Tracleer24$229,389$9,558
Sildenafil133$133,149$1,001
Valganciclovir50$116,347$2,327
Opsumit12$92,906$7,742
Sporanox13$16,753$1,289
Atovaquone15$13,153$877
Nexium17$6,873$404
Tacrolimus42$4,652$111
Mycophenolate Mofetil37$2,946$80
Prednisone103$1,132$11
Pantoprazole107$1,081$10
Sulfamethoxazole-Trimethoprim118$1,078$9
Potassium Chloride26$725$28
Metoprolol95$559$6
Escitalopram11$391$36
Bd Ultra-Fine Pen Needle11$390$35
Acyclovir15$371$25
Azithromycin13$288$22
Finasteride17$266$16
Ranitidine24$241$10
Atorvastatin20$217$11
Furosemide43$202$5
Gabapentin14$168$12
Tramadol14$69$5
Amlodipine Besylate13$31$2

2015: 37 drugs

Part D drugs prescribed in 2015
Letairis267$1,895,107$7,098
Adcirca169$455,848$2,697
Tracleer38$321,196$8,453
Revatio38$312,515$8,224
Valganciclovir77$283,148$3,677
Tyvaso11$156,908$14,264
Sildenafil119$87,120$732
Opsumit11$81,406$7,401
Atovaquone44$65,337$1,485
Valcyte19$58,575$3,083
Sporanox24$30,592$1,275
Enoxaparin16$12,468$779
Nexium18$11,324$629
Novolog Flexpen17$7,041$414
Crestor19$5,367$282
Mycophenolate Mofetil50$4,976$100
Levemir Flextouch11$4,136$376
Tacrolimus32$4,020$126
Potassium Chloride37$1,530$41
Pantoprazole88$1,510$17
Prednisone108$1,155$11
Sulfamethoxazole-Trimethoprim119$1,126$9
Azithromycin18$800$44
Bd Ultra-Fine Pen Needle16$605$38
Atorvastatin41$483$12
Metoprolol94$472$5
Acyclovir15$396$26
Omeprazole20$380$19
Enalapril Maleate11$233$21
Fluticasone Propionate17$223$13
Levothyroxine11$216$20
Furosemide40$195$5
Ranitidine20$157$8
Spironolactone13$152$12
Zolpidem12$142$12
Tramadol22$136$6
Amlodipine Besylate14$50$4

2014: 43 drugs

Part D drugs prescribed in 2014
Letairis242$1,613,951$6,669
Valcyte148$612,436$4,138
Adcirca160$361,954$2,262
Tracleer47$359,494$7,649
Revatio46$349,786$7,604
Sildenafil83$113,168$1,363
Noxafil12$110,886$9,240
Opsumit11$77,327$7,030
Mepron23$56,302$2,448
Voriconazole27$53,513$1,982
Atovaquone31$50,211$1,620
Sporanox22$26,257$1,194
Enoxaparin20$18,716$936
Nexium33$17,672$536
Tacrolimus46$10,580$230
Mycophenolate Mofetil53$4,932$93
Novolog Flexpen13$4,525$348
Crestor11$3,184$289
Pantoprazole117$2,299$20
Prednisone114$1,595$14
Azithromycin40$1,575$39
Potassium Chloride35$1,358$39
Sulfamethoxazole-Trimethoprim134$1,138$8
Metoprolol117$751$6
Atorvastatin40$691$17
Klor-Con M2012$654$55
Omeprazole33$643$19
Bd Ultra-Fine Pen Needle13$504$39
Amikacin Sulfate12$469$39
Tamsulosin24$403$17
Fluticasone Propionate12$225$19
Klor-Con 1012$213$18
Hydrocodone-Acetaminophen18$192$11
Spironolactone18$178$10
Zolpidem27$156$6
Furosemide34$155$5
Alprazolam14$128$9
Ranitidine17$123$7
Enalapril Maleate12$103$9
Tramadol12$92$8
Warfarin13$73$6
Lisinopril11$60$5
Fluoxetine12$55$5

2013: 33 drugs

Part D drugs prescribed in 2013
Letairis252$1,611,796$6,396
Valcyte103$416,212$4,041
Revatio58$340,137$5,864
Tracleer47$324,331$6,901
Adcirca179$320,875$1,793
Tyvaso12$187,833$15,653
Sildenafil83$134,183$1,617
Mepron22$37,129$1,688
Voriconazole14$22,850$1,632
Enoxaparin16$18,868$1,179
Sporanox15$15,865$1,058
Nexium30$13,595$453
Tacrolimus27$11,133$412
Itraconazole11$8,396$763
Mycophenolate Mofetil42$4,909$117
Clonidine12$1,710$142
Atorvastatin44$1,600$36
Pantoprazole72$1,133$16
Azithromycin19$1,014$53
Sulfamethoxazole-Trimethoprim122$923$8
Omeprazole22$547$25
Prednisone72$484$7
Metoprolol56$452$8
Fluticasone Propionate15$439$29
Potassium Chloride19$424$22
Ulticare14$423$30
Klor-Con M2018$420$23
Hydrocodone-Acetaminophen15$256$17
Zolpidem36$219$6
Alprazolam15$135$9
Furosemide24$128$5
Tramadol12$109$9
Enalapril Maleate12$66$5

Money from drug and device companies

$3,992 in 2025

Industry payments by year
202559$3,400$3,992
2024523$10,047$21,990
2023417$7,046$10,859
2022525$9,568$14,022
2021519$17,710$18,721
2020438$23,923$27,654
2019583$57,900$68,911

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
United TherapeuticsTyvaso$3,147
3 payments
  • Consulting for Tyvaso · 2025-08-01 · $2,900
  • Meals · 2025-07-31 · $120
  • Meals for Tyvaso · 2025-05-08 · $127
Pierre Fabre PharmaceuticalsNone$602
2 payments
  • Honoraria · 2025-02-27 · $500
  • Meals · 2025-02-27 · $102
KamadaCytogam$116
2 payments
  • Meals for Cytogam · 2025-05-17 · $79
  • Meals for Cytogam · 2025-01-21 · $37
TherakosNone$92
1 payment
  • Meals · 2025-06-10 · $92
La Jolla PharmaceuticalGiapreza$34
1 payment
  • Meals for Giapreza · 2025-08-04 · $34
See all 9 published payments
Every published payment
La Jolla PharmaceuticalMeals · 2025-08-04Giapreza$34
United TherapeuticsConsulting · 2025-08-01Tyvaso$2,900
United TherapeuticsMeals · 2025-07-31None$120
TherakosMeals · 2025-06-10None$92
KamadaMeals · 2025-05-17Cytogam$79
United TherapeuticsMeals · 2025-05-08Tyvaso$127
Pierre Fabre PharmaceuticalsHonoraria · 2025-02-27None$500
Pierre Fabre PharmaceuticalsMeals · 2025-02-27None$102
KamadaMeals · 2025-01-21Cytogam$37
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $21,990

Payments by company in 2024
Merck Sharp & DohmeWinrevair$12,256
7 payments
  • Paid to speak or teach · 2024-10-09 · $750
  • Travel · 2024-09-29 · $396
  • Travel · 2024-09-23 · $499
  • Travel for Winrevair · 2024-06-12 · $206
  • Travel for Winrevair · 2024-06-11 · $206
  • Travel for Winrevair · 2024-06-10 · $206
  • Travel for Winrevair · 2024-06-09 · $9,992
Zambon USANone$6,788
8 payments
  • Consulting · 2024-04-19 · $5,650
  • Consulting · 2024-04-19 · $242
  • Consulting · 2024-04-19 · $35
  • Consulting · 2024-04-19 · $48
  • Consulting · 2024-04-19 · $50
  • Consulting · 2024-04-19 · $48
  • Consulting · 2024-04-18 · $675
  • Meals · 2024-01-30 · $41
KamadaCytogam$2,550
1 payment
  • Paid to speak or teach for Cytogam · 2024-09-10 · $2,550
Paragonix TechnologiesSherpapak$282
4 payments
  • Meals · 2024-04-11 · $143
  • Meals · 2024-04-11 · $2
  • Meals · 2024-04-11 · $15
  • Meals for Sherpapak · 2024-01-22 · $122
United TherapeuticsSteen Solution$114
3 payments
  • Meals for Steen Solution · 2024-08-22 · $41
  • Meals · 2024-07-01 · $36
  • Meals · 2024-05-02 · $37

2023: $10,859

Payments by company in 2023
Zambon USANone$9,449
13 payments
  • Paid to speak or teach · 2023-11-30 · $4,025
  • Travel · 2023-11-30 · $433
  • Travel · 2023-11-09 · $126
  • Meals · 2023-11-07 · $57
  • Travel · 2023-11-07 · $49
  • Travel · 2023-10-23 · $375
  • Honoraria · 2023-04-18 · $3,000
  • Meals · 2023-03-29 · $80
  • Meals · 2023-03-29 · $70
  • Travel · 2023-03-29 · $66
  • Meals · 2023-03-29 · $76
  • Travel · 2023-03-28 · $852
  • Travel · 2023-03-28 · $240
Merck Sharp & DohmeNone$1,315
1 payment
  • Travel · 2023-09-23 · $1,315
United TherapeuticsTyvaso$55
2 payments
  • Meals for Tyvaso · 2023-06-27 · $34
  • Consulting · 2023-01-03 · $21
KamadaCytogam$39
1 payment
  • Meals for Cytogam · 2023-09-26 · $39

2022: $14,022

Payments by company in 2022
Zambon USANone$10,096
12 payments
  • Travel · 2022-12-04 · $34
  • Travel · 2022-12-02 · $163
  • Meals · 2022-12-02 · $9
  • Travel · 2022-12-02 · $1,601
  • Honoraria · 2022-12-02 · $4,255
  • Travel · 2022-12-02 · $39
  • Meals · 2022-12-02 · $14
  • Travel · 2022-12-01 · $35
  • Travel · 2022-12-01 · $51
  • Meals · 2022-10-18 · $54
  • Paid to speak or teach · 2022-10-18 · $3,000
  • Travel · 2022-10-18 · $841
InsmedArikayce$2,313
2 payments
  • Consulting for Arikayce · 2022-11-10 · $1,100
  • Consulting for Arikayce · 2022-04-05 · $1,213
Sanofi-Aventis U.S.None$1,276
3 payments
  • Travel · 2022-09-25 · $652
  • Travel · 2022-09-25 · $447
  • Travel · 2022-09-25 · $177
United TherapeuticsTyvaso$321
7 payments
  • Meals · 2022-11-14 · $60
  • Meals for Tyvaso · 2022-09-06 · $84
  • Meals for Tyvaso · 2022-05-15 · $24
  • Meals for Tyvaso · 2022-04-28 · $10
  • Meals · 2022-04-28 · $123
  • Meals · 2022-04-27 · $17
  • Education for Orenitram · 2022-04-22 · $3
Actelion Pharmaceuticals USNone$17
1 payment
  • Meals · 2022-05-14 · $17

2021: $18,721

Payments by company in 2021
Actelion Pharmaceuticals USUptravi$10,613
4 payments
  • Consulting for Opsumit · 2021-12-16 · $2,525
  • Consulting for Uptravi · 2021-10-21 · $3,030
  • Meals for Opsumit · 2021-10-14 · $8
  • Consulting for Uptravi · 2021-04-16 · $5,050
InsmedArikayce$3,941
8 payments
  • Paid to speak or teach for Arikayce · 2021-08-04 · $2,668
  • Meals for Arikayce · 2021-08-04 · $13
  • Travel for Arikayce · 2021-08-04 · $209
  • Travel for Arikayce · 2021-08-04 · $416
  • Meals for Arikayce · 2021-08-04 · $119
  • Meals for Arikayce · 2021-05-14 · $18
  • Meals for Arikayce · 2021-05-03 · $12
  • Paid to speak or teach for Arikayce · 2021-04-19 · $485
United TherapeuticsTyvaso$2,175
5 payments
  • Meals for Orenitram · 2021-06-15 · $91
  • Meals for Tyvaso · 2021-05-04 · $59
  • Meals for Tyvaso · 2021-05-04 · $3
  • Paid to speak or teach · 2021-04-09 · $1,960
  • Meals for Tyvaso · 2021-03-22 · $63
One LambdaNone$1,500
1 payment
  • Honoraria · 2021-03-05 · $1,500
Vertex PharmaceuticalsNone$492
1 payment
  • Consulting · 2021-02-23 · $492

2020: $27,654

Payments by company in 2020
InsmedArikayce$17,906
34 payments
  • Consulting for Arikayce · 2020-12-01 · $1,125
  • Paid to speak or teach · 2020-11-05 · $450
  • Consulting for Arikayce · 2020-10-20 · $1,125
  • Paid to speak or teach · 2020-09-01 · $450
  • Consulting for Arikayce · 2020-08-01 · $900
  • Meals for Arikayce · 2020-07-27 · $10
  • Meals for Arikayce · 2020-04-16 · $13
  • Travel for Arikayce · 2020-02-28 · $550
  • Paid to speak or teach for Arikayce · 2020-02-12 · $2,475
  • Meals · 2020-02-11 · $121
  • Meals · 2020-02-06 · $18
  • Travel · 2020-02-06 · $35
  • Travel · 2020-02-06 · $483
  • Meals · 2020-02-06 · $13
  • Travel · 2020-02-06 · $90
  • Travel · 2020-02-04 · $150
  • Travel · 2020-02-04 · $374
  • Travel · 2020-02-04 · $296
  • Travel · 2020-02-04 · $213
  • Meals · 2020-02-04 · $16
  • Meals · 2020-02-04 · $115
  • Travel · 2020-02-04 · $170
  • Meals · 2020-02-04 · $25
  • Consulting for Arikayce · 2020-01-30 · $900
  • Meals for Arikayce · 2020-01-28 · $49
  • Paid to speak or teach · 2020-01-27 · $2,475
  • Paid to speak or teach · 2020-01-27 · $900
  • Paid to speak or teach · 2020-01-27 · $2,475
  • Paid to speak or teach · 2020-01-27 · $900
  • Meals for Arikayce · 2020-01-23 · $24
  • Travel · 2020-01-15 · $178
  • Travel for Arikayce · 2020-01-15 · $151
  • Travel · 2020-01-15 · $397
  • Travel for Arikayce · 2020-01-15 · $240
Actelion Pharmaceuticals USUptravi$4,798
1 payment
  • Consulting for Uptravi · 2020-12-23 · $4,798
United TherapeuticsOrenitram$2,950
2 payments
  • Paid to speak or teach · 2020-12-23 · $100
  • Consulting for Orenitram · 2020-12-11 · $2,850
GlaxoSmithKlineNone$2,000
1 payment
  • Consulting · 2020-12-07 · $2,000

2019: $68,911

Payments by company in 2019
InsmedArikayce$54,320
74 payments
  • Meals for Arikayce · 2019-12-20 · $116
  • Meals for Arikayce · 2019-12-20 · $16
  • Travel · 2019-12-13 · $271
  • Meals · 2019-12-13 · $122
  • Meals · 2019-12-13 · $4
  • Meals · 2019-12-13 · $20
  • Paid to speak or teach for Arikayce · 2019-12-09 · $3,825
  • Paid to speak or teach · 2019-12-09 · $3,825
  • Paid to speak or teach · 2019-12-09 · $1,575
  • Paid to speak or teach for Arikayce · 2019-12-09 · $1,575
  • Travel · 2019-12-05 · $512
  • Travel · 2019-12-05 · $392
  • Travel for Arikayce · 2019-11-22 · $353
  • Meals for Arikayce · 2019-11-22 · $30
  • Travel for Arikayce · 2019-11-22 · $48
  • Travel for Arikayce · 2019-11-20 · $440
  • Meals for Arikayce · 2019-11-20 · $108
  • Paid to speak or teach for Arikayce · 2019-11-11 · $2,475
  • Travel for Arikayce · 2019-10-18 · $506
  • Consulting · 2019-10-13 · $900
  • Travel · 2019-09-13 · $54
  • Meals · 2019-09-13 · $32
  • Travel · 2019-09-11 · $230
  • Meals for Arikayce · 2019-09-10 · $93
  • Travel · 2019-09-03 · $263
  • Paid to speak or teach · 2019-08-23 · $3,825
  • Consulting for Arikayce · 2019-08-13 · $450
  • Travel · 2019-08-08 · $460
  • Travel · 2019-07-01 · $42
  • Meals · 2019-07-01 · $21
  • Travel for Arikayce · 2019-07-01 · $38
  • Meals for Arikayce · 2019-07-01 · $18
  • Travel · 2019-07-01 · $27
  • Meals · 2019-07-01 · $20
  • Paid to speak or teach · 2019-06-25 · $1,575
  • Meals for Arikayce · 2019-06-20 · $133
  • Travel for Arikayce · 2019-06-20 · $613
  • Travel for Arikayce · 2019-06-15 · $455
  • Meals for Arikayce · 2019-06-14 · $86
  • Meals for Arikayce · 2019-06-13 · $41
  • Paid to speak or teach for Arikayce · 2019-06-13 · $2,475
  • Travel for Arikayce · 2019-06-13 · $513
  • Paid to speak or teach for Arikayce · 2019-06-13 · $2,475
  • Travel · 2019-06-13 · $202
  • Meals · 2019-06-13 · $106
  • Travel · 2019-06-13 · $202
  • Travel for Arikayce · 2019-06-10 · $164
  • Meals · 2019-05-28 · $145
  • Travel · 2019-05-28 · $168
  • Meals · 2019-05-28 · $18
  • Travel · 2019-05-28 · $181
  • Travel · 2019-05-21 · $254
  • Travel · 2019-05-21 · $184
  • Travel · 2019-05-21 · $214
  • Meals for Arikayce · 2019-05-18 · $18
  • Paid to speak or teach · 2019-05-17 · $2,475
  • Paid to speak or teach · 2019-05-17 · $1,575
  • Travel for Arikayce · 2019-05-07 · $27
  • Consulting for Arikayce · 2019-05-04 · $6,400
  • Travel for Arikayce · 2019-05-04 · $480
  • Travel for Arikayce · 2019-05-04 · $287
  • Travel for Arikayce · 2019-05-04 · $271
  • Meals for Arikayce · 2019-05-04 · $40
  • Meals for Arikayce · 2019-05-04 · $14
  • Meals for Arikayce · 2019-05-04 · $50
  • Travel for Arikayce · 2019-05-04 · $27
  • Meals for Arikayce · 2019-04-27 · $40
  • Meals for Arikayce · 2019-04-27 · $22
  • Meals for Arikayce · 2019-04-27 · $50
  • Travel for Arikayce · 2019-04-26 · $275
  • Meals for Arikayce · 2019-04-26 · $125
  • Travel for Arikayce · 2019-04-26 · $720
  • Travel for Arikayce · 2019-04-26 · $209
  • Paid to speak or teach for Arikayce · 2019-04-16 · $8,325
Actelion Pharmaceuticals USUptravi$12,718
4 payments
  • Consulting for Uptravi · 2019-12-19 · $12,500
  • Meals for Opsumit · 2019-11-13 · $46
  • Meals for Opsumit · 2019-08-14 · $68
  • Meals · 2019-05-19 · $103
One LambdaNone$1,662
3 payments
  • Meals · 2019-04-03 · $162
  • Honoraria · 2019-04-02 · $1,000
  • Honoraria · 2019-02-12 · $500
Alexion PharmaceuticalsSoliris$150
1 payment
  • Honoraria for Soliris · 2019-06-27 · $150
United TherapeuticsOrenitram$62
1 payment
  • Meals for Orenitram · 2019-01-16 · $62

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
United Therapeutics Corporation · A Multicenter Randomized Double-Blinded Placebo-Controlled Trial To Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2019Their institution$20,494
United Therapeutics Corporation · An Open-Label Extension Study of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2019Their institution$15,022
Actelion Pharmaceuticals, Ltd · Trace · 2019Their institution$11,336
United Therapeutics Corporation · An Open-Label Extension Study of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2020Their institution$6,776
United Therapeutics Corporation · An Open-Label Extension Study of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2021Their institution$4,295
United Therapeutics Corporation · A Multicenter Randomized Double-Blinded Placebo-Controlled Trial To Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2021Their institution$3,629
Biotest AG · Igm/Iga · 2019Their institution$2,819
United Therapeutics Corporation · A Multicenter Randomized Double-Blinded Placebo-Controlled Trial To Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due To Parenchymal Lung Disease · 2020Their institution$631

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1831206804
Licence
CA C181690, TX M1881California C181690: Current · expires 2028-09-30Texas M1881: Canc Non-Renewal
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
TX 162605301
Taxonomy
Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-08-24
NPI last updated
2024-04-12
NPI record certified
2024-04-12

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 4502 Medical Dr, San Antonio, TX, 78229 · 8300 Floyd Curl Dr, San Antonio, TX, 78229